Bausch + Lomb shares tumbled in intraday trading Friday, a day after the eye-care company announced a "voluntary recall" of ...

Eye health company Bausch + Lomb has issued a voluntary recall of a series of intraocular lenses, according to a March 27 ...

Alcon has acquired a majority interest in Aurion Biotech, according to a press release. Aurion will operate as a separate ...

Alcon is one of the leading visioncare companies in the world, with a record of successful product development, and it will continue to launch technically superior products.

Bausch + Lomb said on Thursday it will recall some of its implantable eye lenses after receiving reports of complications, ...

Most cases of TASS can be treated with steroids within a few days, although severe cases can lead to permanent damage to the ...

Bausch + Lomb has reported a “voluntary recall” of certain intraocular lenses (IOLs) on its enVista platform due to complications.

The CEOs say the merger could be transformative for robotic laser technology in the cataract surgery industry.

Alcon (ALC) announced that Vivity, the most widely implanted extended depth of focus intraocular lens, is now available on Alcon’s most ...

ALC secures CE Mark for Clareon Vivity IOL, bringing advanced presbyopia-correcting lens technology to Europe, enhancing ...

Alcon ALC and LENSAR, Inc. LNSR, a global medical technology company focused on advanced laser solutions for the treatment of cataracts, recently entered into a definitive merger agreement. Per the ...

Investing.com -- Alcon (SIX: ALCC) has received an upgrade to a "buy" rating from BofA Securities in a note dated Tuesday, signaling the beginning of an earnings growth cycle for the Swiss eye care ...